WATSON 836 7.5 Pill - beige five-sided
Pill with imprint WATSON 836 7.5 is Beige, Five-sided and has been identified as Clorazepate Dipotassium 7.5 mg. It is supplied by Watson Laboratories, Inc.
Clorazepate is used in the treatment of Alcohol Withdrawal; Anxiety; Seizure Prevention; Seizures; Epilepsy and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 7.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WATSON 836 7.5
Clorazepate Dipotassium
- Imprint
- WATSON 836 7.5
- Strength
- 7.5 mg
- Color
- Beige
- Shape
- Five-sided
- Availability
- Prescription only
- Drug Class
- Benzodiazepines
- Pregnancy Category
- N - Not classified
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 52544-0836 (Discontinued)
More about clorazepate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (56)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: benzodiazepines
- Breastfeeding
- En español
Patient resources
Other brands
Tranxene, Tranxene T-Tab, Tranxene SD
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.